703 Millennium - Seventeenth Edition SCIENCES, PHARMACEUTICALS AND BIOTECHNOLOGY CHIEF GROWTH OFFICER Lynker Reisterstown, MD FOUNDER, EXECUTIVE OFFICER iSeek Biopharma Inc. Albuquerque, NM ANTHONY R. MARANTO, PHD Leveraging expertise in environmental science and chemistry, Dr. Anthony R. Maranto has earned distinction as the chief growth officer at Lynker. The science, engineering and technology company is committed to supporting the nation’s most important scientific projects. Having previously served as the vice president of strategic pursuits, he currently manages projects valued at over $1.5 billion. Dr. Maranto similarly supports environmental projects on behalf of the National Ocean Service, the National Marine Fisheries Service and the National Weather Service. Likewise, his work has aided the success of NASA and NOAA satellite and ground systems and numerous science programs for the U.S. Department of Defense and the National Institutes of Health. Dr. Maranto’s multifaceted career spans over 30 years, having also worked with ERT Inc., Columbus Technologies and Booz Allen Hamilton. Since obtaining a PhD in environmental science at Union Institute & University in 1997, he has attributed much of his success to his open-minded approach to new opportunities. Looking ahead, he hopes to continue supporting environmental sustainability, space exploration and national defense. Leveraging over three decades of experience, Dr. Jeff P. Norenberg has become recognized for his work as the founder and CEO of iSeek BioPharma Inc., a startup company specializing in the development of radiopharmaceuticals. Intent on leading the company to preeminence in the field of imaging drugs, he is proud of the strides iSeek has already made in alleviating the suffering of patients afflicted with infection or inflammation. Dr. Norenberg previously found success in academia, leading the radiopharmaceutical sciences program at the University of New Mexico. He also taught students at the College of Pharmacy in the School of Medicine. He also served as the executive director of the National Association of Nuclear Pharmacies. Attributing his success to curiosity and ambition, Dr. Norenberg bears a multitude of designations, having most recently studied molecular medicine at Erasmus University Rotterdam, where he earned a PhD in 2013. Throughout his career, he has published numerous articles that have appeared in various prominent scientific journals. Looking ahead, Dr. Norenberg aims to keep an open mind regarding the future and to serve as an excellent parent for his children. JEFF P. NORENBERG, PHARMD, PHD
RkJQdWJsaXNoZXIy MTQ5NDA2